Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Ingerman

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Infectious Disease Clinics of North America|September 1, 1989
Vancomycin. A new old agentM J Ingerman, J Santoro
The Journal of Infectious Diseases|July 1, 1991
Development of Listeria meningitis during vancomycin therapy: a case reportJ S Baldassarre, M J Ingerman, J Nansteel, et al.
Infectious Disease Clinics of North America|September 1, 1995
Antibacterial agents in renal failureL L Livornese, R L Benz, M J Ingerman, et al.
The Journal of Infectious Diseases|April 1, 1986
The importance of pharmacodynamics in determining the dosing interval in therapy for experimental pseudomonas endocarditis in the ratM J Ingerman, P G Pitsakis, A F Rosenberg, et al.
Infectious Disease Clinics of North America|September 26, 2001
Use of antibacterial agents in renal failureL L Livornese, D Slavin, R L Benz, et al.
Infectious Disease Clinics of North America|June 1, 2000
Use of antibacterial agents in renal failureL L Livornese, D Slavin, R L Benz, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1986
Comparison of two beta-lactamase-producing strains of Streptococcus faecalisB E Murray, D A Church, A Wanger, et al.
The American Journal of Medicine|April 27, 1987
Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitisM T Hessen, M J Ingerman, D H Kaufman, et al.
JAMA|November 30, 1999
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapyG Dornadula, H Zhang, B VanUitert, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Infectious Disease Clinics of North America|September 1, 1989
Vancomycin. A new old agentM J Ingerman, J Santoro
The Journal of Infectious Diseases|July 1, 1991
Development of Listeria meningitis during vancomycin therapy: a case reportJ S Baldassarre, M J Ingerman, J Nansteel, et al.
Infectious Disease Clinics of North America|September 1, 1995
Antibacterial agents in renal failureL L Livornese, R L Benz, M J Ingerman, et al.
The Journal of Infectious Diseases|April 1, 1986
The importance of pharmacodynamics in determining the dosing interval in therapy for experimental pseudomonas endocarditis in the ratM J Ingerman, P G Pitsakis, A F Rosenberg, et al.
Infectious Disease Clinics of North America|September 26, 2001
Use of antibacterial agents in renal failureL L Livornese, D Slavin, R L Benz, et al.
Infectious Disease Clinics of North America|June 1, 2000
Use of antibacterial agents in renal failureL L Livornese, D Slavin, R L Benz, et al.
Antimicrobial Agents and Chemotherapy|December 1, 1986
Comparison of two beta-lactamase-producing strains of Streptococcus faecalisB E Murray, D A Church, A Wanger, et al.
The American Journal of Medicine|April 27, 1987
Clinical efficacy of ciprofloxacin therapy for gram-negative bacillary osteomyelitisM T Hessen, M J Ingerman, D H Kaufman, et al.
JAMA|November 30, 1999
Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapyG Dornadula, H Zhang, B VanUitert, et al.
Pageof 1